Johnson & Johnson Vision Acquires Sightbox


Acquisition will help more patients connect with eye care professionals through a member-based contact lens subscription service

JACKSONVILLE, FL, September 18, 2017 – Johnson & Johnson Vision today announced that it has acquired Sightbox, Inc., an online, membership-based subscription service for contact lens wearers in the United States. Sightbox helps patients connect with eye care professionals and addresses a growing consumer preference for more convenient access to eye health services and products.

Sightbox services include scheduling a comprehensive, annual eye exam and contact lens evaluation for members, as well as providing them with an annual supply of contact lenses. The company’s growth has been primarily fueled by private pay patients who do not have vision insurance. This model encourages people who may not otherwise do so to visit an eye care professional and enter the category.

"Consumer preferences and digital technologies are accelerating a broad shift to e-commerce across many industries," said Ashley McEvoy, Company Group Chairman, responsible for the Johnson & Johnson Vision Companies. "We are excited about how Sightbox can potentially fuel category growth by meeting consumers where and how they want, and by helping more contact lens wearers connect with eye care professionals through this concierge-type service."

While Sightbox will become part of Johnson & Johnson Vision, it will operate as a separate business, leveraging its own unique business model. Sightbox will continue to provide contact lenses from all major manufacturers. The acquisition is complementary to Johnson & Johnson Vision’s strategy to become a broad-based, global leader in eye health. It further enhances the company’s leading eye health portfolio.

Sightbox marks the third acquisition completed this calendar year that expands the offerings of Johnson & Johnson Vision. The first – Abbott Medical Optics, acquired in February – included cataract, refractive and consumer eye care products. TearScience, acquired in September, added medical device technologies that address Meibomian Gland Disease, the leading cause of Dry Eye, to the Johnson & Johnson Vision portfolio.

Johnson & Johnson Vision acquired Sightbox, Inc. through its Vision Care operating company, Johnson & Johnson Vision Care, Inc. Sightbox sales will be reported through the Medical Devices segment, under Vision Care. Financial terms of the transaction have not been disclosed.

About Johnson & Johnson

Caring for the world one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 132,500 employees at more than 230 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Johnson & Johnson Vision

Johnson & Johnson Vision, through its operating companies, is committed to improving and restoring sight for patients worldwide. Since debuting the world’s first disposable soft contact lens in 1987, Johnson & Johnson Vision Care, Inc. has been helping patients see better through their world-leading ACUVUE® Brand Contact Lenses portfolio. In 2017, with the addition of Abbott Medical Optics Inc., the Johnson & Johnson Surgical Vision business, Johnson & Johnson Vision invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK) and consumer eye health. Serving more than 60 million patients across 103 countries, Johnson & Johnson Vision is committed to helping more people in more places improve or restore their sight. Dual headquartered in Jacksonville, Florida, and Santa Ana, California, Johnson & Johnson Vision has more than 10,000 employees worldwide.

Media Contact: Donna Lorenson (410) 258-8571


Cautions Concerning Forward-Looking Statements

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 related to the acquisition of Sightbox. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson Vision and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: challenges related to integrating the products and employees/operations of Sightbox, as well as the ability to ensure continued performance or market growth of the products of Sightbox; the potential that the expected benefits and opportunities related to the transaction may not be realized or may take longer to realize than expected; challenges inherent in product research and development, including the uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new products; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; competition, including technological advances, new products and patents attained by competitors; challenges to patents; changes to applicable laws and regulations, including tax laws and global health care reforms; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 1, 2017, including under "Item 1A. Risk Factors," its most recently filed Quarterly Report on Form 10-Q, including under the caption "Cautionary Note Regarding Forward-Looking Statements," and the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at, or on request from Johnson & Johnson. Johnson & Johnson Vision and Johnson & Johnson do not undertake to update any forward-looking statement as a result of new information or future events or developments.